Tumor suppressor gene

Jump to: navigation, search

WikiDoc Resources for Tumor suppressor gene

Articles

Most recent articles on Tumor suppressor gene

Most cited articles on Tumor suppressor gene

Review articles on Tumor suppressor gene

Articles on Tumor suppressor gene in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Tumor suppressor gene

Images of Tumor suppressor gene

Photos of Tumor suppressor gene

Podcasts & MP3s on Tumor suppressor gene

Videos on Tumor suppressor gene

Evidence Based Medicine

Cochrane Collaboration on Tumor suppressor gene

Bandolier on Tumor suppressor gene

TRIP on Tumor suppressor gene

Clinical Trials

Ongoing Trials on Tumor suppressor gene at Clinical Trials.gov

Trial results on Tumor suppressor gene

Clinical Trials on Tumor suppressor gene at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Tumor suppressor gene

NICE Guidance on Tumor suppressor gene

NHS PRODIGY Guidance

FDA on Tumor suppressor gene

CDC on Tumor suppressor gene

Books

Books on Tumor suppressor gene

News

Tumor suppressor gene in the news

Be alerted to news on Tumor suppressor gene

News trends on Tumor suppressor gene

Commentary

Blogs on Tumor suppressor gene

Definitions

Definitions of Tumor suppressor gene

Patient Resources / Community

Patient resources on Tumor suppressor gene

Discussion groups on Tumor suppressor gene

Patient Handouts on Tumor suppressor gene

Directions to Hospitals Treating Tumor suppressor gene

Risk calculators and risk factors for Tumor suppressor gene

Healthcare Provider Resources

Symptoms of Tumor suppressor gene

Causes & Risk Factors for Tumor suppressor gene

Diagnostic studies for Tumor suppressor gene

Treatment of Tumor suppressor gene

Continuing Medical Education (CME)

CME Programs on Tumor suppressor gene

International

Tumor suppressor gene en Espanol

Tumor suppressor gene en Francais

Business

Tumor suppressor gene in the Marketplace

Patents on Tumor suppressor gene

Experimental / Informatics

List of terms related to Tumor suppressor gene

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Overview

A tumor suppressor gene is a gene that reduces the probability that a cell in a multicellular organism will turn into a tumor cell. A mutation or deletion of such a gene will increase the probability of the formation of a tumor.

Two-hit hypothesis

Unlike oncogenes, tumor suppressor genes generally follow the 'two-hit hypothesis,' which implies that both alleles that code for a particular gene must be affected before an effect is manifested. This is due to the fact that if only one allele for the gene is damaged, the second can still produce the correct protein. In other words, tumor suppressors are usually not haploinsufficient, although there are notable exceptions (the p53 gene product).

Functions

Tumor suppressor genes, or more precisely, the proteins for which they code, either have a dampening or repressive effect on the regulation of the cell cycle or promote apoptosis, and sometimes do both. The functions of tumor suppressor proteins fall into several categories including the following:[1]

  1. Repression of genes that are essential for the continuing of the cell cycle. If these genes are not expressed, the cell cycle will not continue, effectively inhibiting cell division.
  2. Coupling the cell cycle to DNA damage. As long as there is damaged DNA in the cell, it should not divide. If the damage can be repaired, the cell cycle can continue.
  3. If the damage can not be repaired, the cell should initiate apoptosis, or programmed cell death, to remove the threat it poses for the greater good of the organism.
  4. Some proteins involved in cell adhesion prevent tumor cells from dispersing, block loss of contact inhibition, and inhibit metastasis.[2]

Examples

The first tumor suppressor protein discovered was the pRb protein in human retinoblastoma; however, recent evidence has also implicated pRb as a tumor survival factor.

Another important tumor suppressor is the p53 tumor suppressor protein produced by the TP53 gene.

PTEN acts by opposing the action of PI3K, which is essential for anti-apoptotic, pro-tumorogenic Akt activation.

See also

References

  1. Sherr C (2004). "Principles of tumor suppression". Cell. 116 (2): 235–46. PMID 14744434. 
  2. Hirohashi S, Kanai Y (2003). "Cell adhesion system and human cancer morphogenesis". Cancer Sci. 94 (7): 575–81. PMID 12841864. 

External links

da:Tumorsuppressorgen

de:Tumorsuppressorgennl:Tumorsuppressorgensk:Tumor-supresorový gén fi:Kasvunrajoitegeeni sv:Tumörsuppressorgen



Linked-in.jpg